EMEA-000253-PIP01-08

Key facts

Active substance
  • nicotinic acid
  • simvastatin
  • laropiprant
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/71/2008
PIP number
EMEA-000253-PIP01-08
Pharmaceutical form(s)
Modified-release tablet
Condition(s) / indication(s)
Hypercholesterolaemia
Route(s) of administration
Oral use
Contact for public enquiries
Merck Sharp and Dohme (Europe), Inc.
Belgium
Tel. +33 180464738
E-mail: pip.information@merck.com
Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

Topics

How useful was this page?

Add your rating